| Date | Title | Description |
| 17.07.2025 | Cancer Drug Discovery: A Synthetic Lethality Approach Using Integrated Platforms, Upcoming Webinar Hosted by Xtalks | www.collaborativedrug.com
In this free webinar, understand the fundamental principles of synthetic lethality and how this approach creates new opportunities for targeting cancers with specific genetic mutations. Attendees will explore how i... |
| 08.07.2025 | Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth | Optibrium, a leading developer of software and AI solutions for molecular design, today (8 July 2025) announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK busine... |
| 14.05.2024 | FMC Corporation and Optibrium collaboration aims to accelerate the discovery of novel crop protection technologies by leveraging the power of machine learning and artificial intelligence | PHILADELPHIA, May 14, 2024 /PRNewswire/ --
FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced a collaboration with Optibrium, a leading developer of software and artificial intelligence (AI) solutio... |
| 27.02.2024 | Optibrium launches a metabolism prediction software platform tailored to DMPK scientists | Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery
CAMBRIDGE, UK, 27 February 2024 – Optibrium, a leading developer of softwa... |
| 21.06.2022 | Optibrium receives further investment from Kester Capital | Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Second round of funding from existing in... |
| 08.06.2022 | Optibrium expands UK head office with new facilities on Cambridge Innovation Park | Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth a... |
| 24.09.2021 | With Maverick now in Takeda's hands, James Scibetta turns the page; Roivant CMO leaves in favor of small IL-2 biotech | James Scibetta
→ Another CEO opportunity has presented itself for James Scibetta, the chief executive of Maverick Therapeutics when Takeda ponied up $525 million in March to buy its T cell collaborator and integ... |
| 10.09.2021 | Optibrium releases 3D ligand-based design module for StarDrop drug discovery software | Optibrium releases 3D ligand-based design module for StarDrop drug discovery software
10-09-2021
Optibrium Ltd, a developer of software for drug discovery, has announced the release of the latest version of StarDrop™, its comprehensive soft... |
| 29.06.2021 | Optibrium publishes major peer-reviewed study on AI applications to global pharma data | Optibrium publishes major peer-reviewed study on AI applications to global pharma data
29-06-2021
Published in AI Letters, study collaborators Optibrium, Takeda and Intellegens demonstrated the application of deep learning imputation to a g... |
| 20.05.2021 | Optibrium and BioPharmics enter partnership on computational drug design | Optibrium and BioPharmics enter partnership on computational drug design
20-05-2021
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation softwa... |
| 10.02.2021 | Optibrium raises investment to advance computer-aided drug discovery | Optibrium raises investment to advance computer-aided drug discovery
10-02-2021
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery pr... |
| 10.02.2021 | Optibrium raises investment to advance computer-aided drug discovery | Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process.
Optibrium™, a developer of software for drug discovery, today announced i... |
| 20.01.2021 | Optibrium enhances compound design strategies in major upgrade to StarDrop software | Optibrium enhances compound design strategies in major upgrade to StarDrop software
20-01-2021
Optibrium™, a developer of software for drug discovery, has announced the release of the newest version of StarDrop™, a comprehensive software pl... |
| 01.04.2020 | Intellegens and Optibrium achieve further success in Open Source Malaria initiative | Intellegens and Optibrium achieve further success in Open Source Malaria initiative
01-04-2020
Intellegens, AI company with unique deep learning toolset for sparse data, and Optibrium™, leading providers of software and services for drug di... |
| 04.12.2019 | Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds | Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds
04-12-2019
Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug disc... |
| 20.09.2018 | Novel deep learning drug discovery platform gets £1 million innovation boost | Novel deep learning drug discovery platform gets £1 million innovation boost
20-09-2018
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discov... |
| 20.09.2018 | Novel deep learning drug discovery platform gets £1 million innovation boost | Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project.
The programme... |
| 01.03.2018 | Cambridge Innovation Park welcomes new tenants | Cambridge Innovation Park welcomes new tenants
01-03-2018
Cambridge Innovation Park is delighted to announce the arrival of Optibrium within its serviced office space in Blenheim House.
Optibrium is a developer of software for small molecul... |
| 06.02.2014 | Cresset announces International Symposium on Compound Design Technologies | Cresset announces International Symposium on Compound Design Technologies
06-02-2014
Innovative providers of computational chemistry software and services, including Cambridge-based Cresset, announce the ‘International Symposium on Compound... |
| 06.02.2014 | Cresset announces International Symposium on Compound Design Technologies | Innovative providers of computational chemistry software and services, including Cambridge-based Cresset, announce the ‘International Symposium on Compound Design Technologies’ in Japan next month.
Cambridge, UK – 6th February 2014 – Cresse... |
| 12.01.2012 | Optibrium expands StarDrop availability with Apple Mac compatibility | Optibrium expands StarDrop availability with Apple Mac compatibility
12-01-2012
CAMBRIDGE, UK, October 18, 2011 – Optibrium launches StarDrop 5.1, an upgraded version of its software platform that helps scientists to guide the design and se... |
| 12.01.2012 | Optibrium expands StarDrop availability with Apple Mac compatibility | CAMBRIDGE, UK, October 18, 2011 – Optibrium launches StarDrop 5.1, an upgraded version of its software platform that helps scientists to guide the design and selection of high quality, novel compounds in drug discovery. As a result of this ... |
| 12.07.2010 | Scientists’ instincts often impaired by biases when making drug discovery decisions, says... | Scientists’ instincts often impaired by biases when making drug discovery decisions, says...
12-07-2010
Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company... |
| 09.07.2010 | Optibrium secures 25 accounts in first year of business | Optibrium secures 25 accounts in first year of business
09-07-2010
Optibrium, a provider of software solutions for drug discovery, celebrates two significant milestones: its first year of trading and signing its 25th customer.
Based in Camb... |
| 15.02.2010 | Optibrium unveils StarDrop 4.3 | Optibrium unveils StarDrop 4.3
15-02-2010
StarDrop version 4.3 is the first major update of StarDrop from Optibrium. This intuitive software for drug discovery offers advantages over traditional predictive modelling platforms as it specific... |
| 20.11.2009 | Optibrium launches online community for drug optimisation | Optibrium launches online community for drug optimisation
20-11-2009
Optibrium launches its online community, optibrium.com/community, providing a rich environment for users of its StarDrop drug discovery software to interact and gain even ... |
| 16.09.2009 | Optibrium and Molecular Networks collaborate to share complementary technology platforms | Optibrium and Molecular Networks collaborate to share complementary technology platforms
16-09-2009
Optibrium Ltd. and Molecular Networks GmbH today announce plans to further intensify their collaboration and share complementary technology ... |
